Transplantation, Kidney Clinical Trial
Official title:
Single Shot Transversus Abdominis Plane (TAP) Block Versus Sham Block for Analgesia in Donors and Recipients Following Kidney Transplantation
Postoperative pain is a major problem in patients who either donate a kidney or undergo
kidney transplantation. This pain is commonly treated with opioids, which can cause several
side effects, ranging from pruritus, impaired vigilance, and most concerning to severe
respiratory depression. This can be aggravated in the recipient by accumulation of opioid
metabolites secondary to renal impairment and secretion.
Several studies have shown an opioid sparing effect of a transversus abdominis plane (TAP)
block after surgery in the lower abdomen. In the proposed study, we plan to compare the
impact of an ultrasound guided single shot transversus abdominis plane (TAP) block versus a
ultrasound guided sham block with normal saline (placebo) on postoperative pain scores,
postoperative opioid consumption, as well as patient's satisfaction.
The investigators hypothesize, that patients who receive a TAP block will have lower
postoperative pain scores, lower postoperative opioid consumption as well as higher
satisfaction scores.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00189735 -
A Study to Evaluate FK778 in Kidney Transplant Patients
|
Phase 2 | |
Recruiting |
NCT01150487 -
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
|
N/A | |
Completed |
NCT01656343 -
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
|
||
Completed |
NCT02625428 -
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
|
Phase 4 | |
Not yet recruiting |
NCT00617474 -
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
|
Phase 1 | |
Terminated |
NCT00365833 -
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
|
N/A | |
Completed |
NCT00861536 -
Comparison of ATG to Thymoglobuline in Renal Transplantation
|
Phase 4 | |
Completed |
NCT00614081 -
GFR Measurement With Contrast-enhanced Dynamic MRI
|
N/A | |
Completed |
NCT03977051 -
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
|
||
Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
Completed |
NCT04874740 -
Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
|
||
Available |
NCT01236287 -
Special Access for the Use of Voclosporin for Kidney Transplantation
|